{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:20:01Z","timestamp":1789708801316,"version":"4.0.1"},"reference-count":31,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2025,9,28]]},"DOI":"10.3960\/jslrt.25043","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:08:15Z","timestamp":1759010895000},"page":"210-217","source":"Crossref","is-referenced-by-count":2,"title":["&lt;i&gt;Schizophyllum&lt;\/i&gt; &lt;i&gt;commune&lt;\/i&gt; infection following chimeric antigen receptor T-cell therapy in a patient with lymphoma"],"prefix":"10.3960","volume":"65","author":[{"given":"Risa","family":"Nishiyama","sequence":"first","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Makita","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Shiotsuka","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Medical Mycology Research Center, Chiba university, Chiba, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko Miyagi","family":"Maeshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Iwaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Munakata","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Izutsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Crump M, Neelapu SS, Farooq U <i>et al.<\/i> Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study [published correction appears in Blood. 2018;131: 587-588]. Blood. 2017;130: 1800-1808."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Makita S, Yoshimura K, Tobinai K. Clinical development of anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma. Cancer Sci. 2017;108: 1109-1118.","DOI":"10.1111\/cas.13239"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Makita S, Imaizumi K, Kurosawa S, Tobinai K. Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges. Drugs Context. 2019;8: 212567.","DOI":"10.7573\/dic.212567"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Strati P, Varma A, Adkins S <i>et al.<\/i> Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma. Haematologica. 2021;106: 2667-2672.","DOI":"10.3324\/haematol.2020.254045"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Stewart AG, Henden AS. Infectious complications of CAR T-cell therapy: a clinical update. Ther Adv Infect Dis. 2021;8: 20499361211036773.","DOI":"10.1177\/20499361211036773"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Chowdhary A, Kathuria S, Agarwal K, Meis JF. Recognizing filamentous basidiomycetes as agents of human disease: a review. Med Mycol. 2014;52: 782-797.","DOI":"10.1093\/mmy\/myu047"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Chowdhary A, Agarwal K, Kathuria S <i>et al.<\/i> Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview. Crit Rev Microbiol. 2014;40: 30-48.","DOI":"10.3109\/1040841X.2012.754401"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Toya T, Shinohara A, Tatsuno K <i>et al.<\/i> A case of Schizophyllum commune sinusitis following unrelated cord blood transplantation for acute lymphoblastic leukemia. Int J Hematol. 2013;98: 261-263.","DOI":"10.1007\/s12185-013-1362-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Yin X, Liang Y, Zeng L, Chen S. A case of sinusitis caused by Schizophyllum commune and bacteria in acute myelocytic leukemia. Clin Lab. 2015;61: 1799-1801.","DOI":"10.7754\/Clin.Lab.2015.150418"},{"key":"10","unstructured":"10 Kawai S, Yamamoto M, Kitazono M <i>et al.<\/i> A case of lung nodule caused by Schizophyllum commune that was diminished by liposomal amphotericin B. Ann Jpn Respir Soc. 2017;6: 165-169."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Narazaki T, Nakashima Y, Tsukamoto Y <i>et al.<\/i> Schizophyllum commune sinusitis after allogeneic bone marrow transplantation for myelodysplastic syndrome: a case report and literature review. Transpl Infect Dis. 2020;22: e13205.","DOI":"10.1111\/tid.13205"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Harada T, Kuriyama T, Nishida R <i>et al.<\/i> Successful allogeneic stem cell transplantation in a case with acute myeloid leukemia and invasive Schizophyllum commune rhinosinusitis. J Infect Chemother. 2020;26: 506-509.","DOI":"10.1016\/j.jiac.2019.12.013"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Hunter ES, Wilopo B, Richardson MD <i>et al.<\/i> Effect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis. Respir Med. 2021;178: 106290.","DOI":"10.1016\/j.rmed.2020.106290"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Agarwal R, Sehgal IS, Muthu V <i>et al.<\/i> Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses. Eur Respir J. 2024;63: 2400061.","DOI":"10.1183\/13993003.00061-2024"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Little JS, Kampouri E, Friedman DZ <i>et al.<\/i> The burden of invasive fungal disease following chimeric antigen receptor T-cell therapy and strategies for prevention. Open Forum Infect Dis. 2024;11: ofae133.","DOI":"10.1093\/ofid\/ofae133"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Reynolds GK, Sim B, Spelman T <i>et al.<\/i> Infections in haematology patients treated with CAR-T therapies: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2023;192: 104134.","DOI":"10.1016\/j.critrevonc.2023.104134"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Garner W, Samanta P, Haidar G. Invasive fungal infections after anti-CD19 chimeric antigen receptor-modified T-cell therapy: state of the evidence and future directions. J Fungi (Basel). 2021;7: 156.","DOI":"10.3390\/jof7020156"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Melica G, Luna de Abia A, Shah GL <i>et al.<\/i> Shift from widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T cell therapy: results from a large retrospective cohort. Transplant Cell Ther. 2025;31: 36-44.","DOI":"10.1016\/j.jtct.2024.10.010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Jain T, Bar M, Kansagra AJ <i>et al.<\/i> Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed\/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American society for transplantation and cellular therapy. Biol Blood Marrow Transplant. 2019;25: 2305-2321.","DOI":"10.1016\/j.bbmt.2019.08.015"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Hayden PJ, Roddie C, Bader P <i>et al.<\/i> Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Ann Oncol. 2022;33: 259-275.","DOI":"10.1016\/j.annonc.2021.12.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Hill JA, Li D, Hay KA <i>et al.<\/i> Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy. Blood. 2018; 131(1): 121-130.","DOI":"10.1182\/blood-2017-07-793760"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Asano K, Oguma T. Allergic bronchopulmonary aspergillosis\/mycosis: an allergic disease or an eosinophilic disease? Intern Med. 2025;64: 493-501.","DOI":"10.2169\/internalmedicine.4386-24"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Oguma T, Taniguchi M, Shimoda T <i>et al.<\/i> Allergic bronchopulmonary aspergillosis in Japan: a nationwide survey. Allergol Int. 2018;67: 79-84.","DOI":"10.1016\/j.alit.2017.04.011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Asano K, Hebisawa A, Ishiguro T <i>et al.<\/i> New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation. J Allergy Clin Immunol. 2021;147: 1261-1268.e5.","DOI":"10.1016\/j.jaci.2020.08.029"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Schwartz RH, Hollick GE. Allergic bronchopulmonary aspergillosis with low serum immunoglobulin E. J Allergy Clin Immunol. 1981;68: 290-294.","DOI":"10.1016\/0091-6749(81)90154-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 M\u00e1iz L, Cuevas M, Quirce S, Pacheco A, Escobar H. Allergic bronchopulmonary aspergillosis with low serum IgE levels in a child with cystic fibrosis. J Allergy Clin Immunol. 1997;100: 431-432.","DOI":"10.1016\/S0091-6749(97)70262-8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Dorsaneo D, Borowitz D, Sharp J, Moss R. Allergic bronchopulmonary aspergillosis with normal serum IgE in a child with cystic fibrosis. Pediatr Asthma Allergy Immunol. 2004;17: 146-150.","DOI":"10.1089\/0883187041269922"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Walker JA, McKenzie ANJ. TH2 cell development and function. Nat Rev Immunol. 2018;18: 121-133.","DOI":"10.1038\/nri.2017.118"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Asano K, Suzuki Y, Tanaka J, Kobayashi K, Kamide Y. Treatments of refractory eosinophilic lung diseases with biologics. Allergol Int. 2023;72: 31-40.","DOI":"10.1016\/j.alit.2022.10.004"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Ishiguro T, Kagiyama N, Kojima A <i>et al.<\/i> Allergic bronchopulmonary mycosis due to Schizophyllum commune treated effectively with voriconazole. Intern Med. 2018;57: 2553-2557.","DOI":"10.2169\/internalmedicine.0668-17"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Strati P, Ahmed S, Furqan F <i>et al.<\/i> Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma. Blood. 2021;137: 3272-3276.","DOI":"10.1182\/blood.2020008865"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/3\/65_25043\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:44:03Z","timestamp":1759553043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/3\/65_25043\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,28]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.25043","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,28]]},"article-number":"25043"}}